Actelion Pharmaceuticals

5000 Shoreline Ct Ste 200 , South San Francisco, CA 94080

Private
Healthcare & Pharmaceuticals - Pharmaceuticals
around $100 - 500M
around 1K - 5K
(650) 624-6900
(650) 589-1501


Actelion Pharmaceuticals is located at 5000 Shoreline Ct Ste 200 , South San Francisco, CA 94080. It has around 1K - 5K employees. Its revenue is around $100 - 500M. Actelion Ltd. is a leading biopharmaceutical company focused on the discovery, development and commercialization of innovative drugs for diseases with significant unmet medical needs. The company has its corporate headquarters in Allschwil/Basel, Switzerland where it was founded in 1997. Its shares have been listed on the SIX Swiss Exchange (ticker symbol ALTN) since 2000. The company has proven its ability to discover new compounds and to rapidly move them from research through development ...

Competitor - 1/9
Which company is more competitive with Actelion Pharmaceuticals?




241 Contacts at this company
Jessica Young
Franchise Marketing Manager
Andrea Connell
Senior Accountant
Liza Rodriguez
Associate Director, U.S. Product Risk ...
Peter Herrmann
Group Compliance Officer
Carol Golden
Greater Philadelphia Area | Professional ...
Jessica Castle
Sr. Manager Medical Science Liaison ...
Steve Kimball
Strategic Market Director
Pam Sperl, Pharm.D.
Senior Director, Medical Science
Brian Nappi
Senior Vice President, Strategy

Sep 16, 2018 19:18:57
ALLSCHWIL, Switzerland--(BUSINESS WIRE)--Actelion Pharmaceuticals Ltd, one of the Janssen Pharmaceutical Companies of Johnson & Johnson, has [...]

Sep 16, 2018 17:31:08
ALLSCHWIL, Switzerland--(BUSINESS WIRE)--Actelion Pharmaceuticals Ltd, one of the Janssen Pharmaceutical Companies of Johnson & Johnson, has [...]

Aug 30, 2018 19:18:40
ALLSCHWIL, Switzerland--(BUSINESS WIRE)--Actelion Pharmaceuticals Ltd, one of the Janssen Pharmaceutical Companies of Johnson & Johnson, today [...]

Aug 30, 2018 17:30:50
ALLSCHWIL, Switzerland--(BUSINESS WIRE)--Actelion Pharmaceuticals Ltd, one of the Janssen Pharmaceutical Companies of Johnson & Johnson, today [...]

Jun 9, 2017 20:43:05
NEW BRUNSWICK, N.J., June 9, 2017 /PRNewswire/ -- Johnson & Johnson (NYSE: JNJ) today announced that, with today\'s receipt of approval of the proposed acquisition of Actelion Ltd [...]

Get Started Today : Sign up in 20 seconds
Search with 20+ criteria.
Export results in seconds.
Bad emails?
No worry, we give two extras for every bad email.